PHARMACY

Camber launches generic Detrol LA

Camber's generic Detrol LA is available in two dosage strengths.
Mayne Pharma launches Lexette foam

Mayne is debuting a foam treatment for adult patients with plaque psoriasis.
Janssen's nasal spray for depression clears FDA committee

If approved, Spravato will offer the first new mechanism of action in 30 years to treat adults with treatment-resistant depression.
Dr. Reddy's launches generic Adcirca tablets

Dr. Reddy's is introducing generic Adcirca, which had a market value of roughly $490 million.
NACDS urges DIR reform in statement to House committee

In comments to the House Ways and Means committee, the National Association of Chain Drug Stores pointed out that DIR fee reform can reduce patients’ out-of-pocket drug costs and overall healthcare spending,
NACDS, NCPA praise groups supporting DIR fee reform

NACDS and NCPA thanked 24 patient and consumer groups for taking a stance in support of DIR fee reform.
Lupin gets FDA nod for generic Prozac

Lupin has received the FDA's nod for generic fluoxetine, which had a market value of roughly $42.5 million for the year ended December 2018.
Fresenius Kabi introduces methocarbamol injection

Methocarbamol injection is used to provide relief for acute, painful musculoskeletal conditions.